EU Agency Backs Omrix Biopharmaceuticals, Inc.'s Drug Evicel

LONDON, July 25 (Reuters) - The European Medicines Agency has recommned approval of Omrix Biopharmaceuticals drug Evicel as supportive treatment in surgery where standard techniques are not enough, the London-based watchdog said on Friday.

MORE ON THIS TOPIC